SCHEMBL6175571

SCHEMBL6175571

CC1(Cc2ccncc2-c2ccccn2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.37
KMT2A Q03164 1/20 0.37
CBFB Q13951 2/20 0.36
FLT1 P17948 1/20 0.35
KDR P35968 1/20 0.35
RUNX1 Q01196 1/20 0.35
GPR39 O43194 1/20 0.35
SCN9A Q15858 2/20 0.35
KCNH2 Q12809 1/20 0.35
SCN5A Q14524 1/20 0.35
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ABL1 P00519 1/20 0.34
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
AR P10275 3/20 0.33
HCRTR1 O43613 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173621 0.86 IGF1R (0.42) TSHRKMT2AAR
SCHEMBL6171903 0.85 IGF1R (0.45) ALDH1A1TSHRKMT2ACYP3A4GAA
SCHEMBL6174749 0.84 AR (0.38) ALDH1A1TSHRKMT2ACYP3A4GAA
SCHEMBL6172098 0.83 AR (0.37) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6173695 0.82 ITGAL (0.40) ALDH1A1KMT2ACYP3A4GAACYP2C9
SCHEMBL6170776 0.82 DGAT2 (0.38) ALDH1A1KCNH2ABL1ARCYP11B1
SCHEMBL6173349 0.82 ALDH1A1 (0.39) ALDH1A1FLT1KDRCYP3A4GAA
SCHEMBL6175943 0.82 ALDH1A1 (0.43) ALDH1A1KMT2AFLT1KDRCYP3A4
SCHEMBL6172435 0.82 POLB (0.38) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6173183 0.81 CYP3A4 (0.39) ALDH1A1FLT1KDRCYP3A4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed